Research | OneLook Acronym Finder |
Serial Number | 90977658 |
Registration Number | 6854115 |
Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
Attorney Name | Paul E. Rauch |
Attorney Docket Number | QLG01-011-TM |
Law Office Assigned | L20 |
Employee Name | RINKER, ANTHONY MICHAE |
2021-03-08 | Application Filed |
2021-08-31 | Published for Opposition |
2022-06-06 | Date of First Use |
2022-07-20 | Location: TMEG LAW OFFICE 102 |
2022-07-20 | Status: Live/Pending |
2022-07-20 | Transaction Date |
2022-09-20 | Trademark Registered |
Owner: | Qualigen, Inc. |
Address | 2042 Corte del Nogal Carlsbad DE 92011 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
260120 | Circles within a circle |
260121 | Circles that are totally or partially shaded. |
261701 | Bands, straight; Bars, straight; Lines, straight; Straight line(s), band(s) or bar(s) |
261706 | Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
DM0000 | The mark consists of A stylized circle having two regions of shading gradients and inside the circle there are a series of dots with some of the dots having a lines originating from the dots or connecting the dots, underneath the stylized circle is the word "qualigen" in a stylized font in lowercase letters, underneath "qualigen" is the word "therapeutics" between the "q" and the "g" of "qualigen" in a stylized font in capital letters and the "i" in "qualigen" has a lighter shaded dot. |
DM0000 | The mark consists of A stylized circle having two regions of shading gradients and inside the circle there are a series of dots with some of the dots having a lines originating from the dots or connecting the dots, underneath the stylized circle is the word "qualigen" in a stylized font in lowercase letters, underneath "qualigen" is the word "therapeutics" between the "q" and the "g" of "qualigen" in a stylized font in capital letters and the "i" in "qualigen" has a lighter shaded dot. |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2021-03-11 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-06-07 | 2 NWOS I:Incoming Correspondence |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2021-06-08 | 3 MDSC E:E-Mail |
ASSIGNED TO EXAMINER | 2021-07-22 | 4 DOCK D:Assigned to Examiner |
EXAMINERS AMENDMENT -WRITTEN | 2021-07-23 | 5 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2021-07-23 | 6 GNEA F:First Action |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-07-23 | 7 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2021-07-23 | 8 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-07-23 | 9 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-08-11 | 10 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2021-08-31 | 11 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-08-31 | 12 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-10-26 | 13 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2022-04-25 | 14 EEXT I:Incoming Correspondence |
SOU EXTENSION 1 FILED | 2022-04-25 | 15 EXT1 S: |
SOU EXTENSION 1 GRANTED | 2022-04-25 | 16 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-04-27 | 17 EXRA E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2022-06-22 | 18 EISU I:Incoming Correspondence |
TEAS REQUEST TO DIVIDE RECEIVED | 2022-06-22 | 19 ERTD I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-07-18 | 20 AITU A:Allowance for Publication |
DIVISIONAL REQUEST RECEIVED | 2022-06-22 | 21 DRRR I:Incoming Correspondence |
DIVISIONAL PROCESSING COMPLETE | 2022-07-20 | 22 DPCC D:Assigned to Examiner |
USE AMENDMENT FILED | 2022-06-22 | 23 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2022-07-20 | 24 SUPC I:Incoming Correspondence |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2022-07-21 | 25 MDSC E:E-Mail |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2022-08-17 | 26 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-08-18 | 27 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2022-09-20 | 28 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-09-20 | 29 NRCC E:E-Mail |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-07-17 | 30 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-07-17 | 31 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-07-17 | 32 TCCA I:Incoming Correspondence |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2023-07-17 | 33 EWAF I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.